[A case report--Efficacy of combination therapy to unresectable advanced gall bladder carcinoma--palliative operation, hepatic arterial infusion therapy, and radiation therapy]

Gan To Kagaku Ryoho. 2004 Oct;31(11):1903-5.
[Article in Japanese]

Abstract

A patient of advanced gall bladder carcinoma with liver metastases and direct invasions to the duodenum and liver underwent a palliative operation, 3 hepatic arterial infusion (HAI) therapies, and radiation therapy at the obstructive common biliary duct. (Palliative operation was a partial resection of duodenum and transverse colon, HAI therapy with 5-FU (1 g/day) was given as a continuous infusion for 6 days, radiation therapy was given 2 Gy/day for 20 times) After the combination therapy, the main tumor of gall bladder and hepatic metastases were decreased and tumor markers were normalized. (CEA 15.1 ng/ml, CA19-9 93 U/ml to CEA 4.4 ng/ml, CA19-9 29 U/ml) Then, an expandable metallic stent (EMS) could be inserted to the stenotic common biliary duct after radiation therapy. Although para-aotic lymph nodes were existent, systemic chemotherapy (UFT 300 mg/day p.o., MMC 2 mg/week div) has been performed as an outpatient with a good quality of life.

Publication types

  • Case Reports
  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antimetabolites, Antineoplastic / administration & dosage*
  • Antineoplastic Agents, Hormonal
  • Biomarkers, Tumor / blood*
  • Combined Modality Therapy
  • Drug Combinations
  • Duodenal Neoplasms / pathology
  • Duodenal Neoplasms / surgery
  • Fluorouracil / administration & dosage*
  • Gallbladder Neoplasms / therapy*
  • Humans
  • Infusions, Intra-Arterial
  • Liver Neoplasms / secondary
  • Male
  • Mitomycin / therapeutic use
  • Palliative Care*
  • Stents
  • Tegafur / therapeutic use
  • Uracil / therapeutic use

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents, Hormonal
  • Biomarkers, Tumor
  • Drug Combinations
  • UFT(R) drug
  • Tegafur
  • Mitomycin
  • Uracil
  • Fluorouracil